FRIDAY, JUNE 13, 2014
Emerging Strategies for the Production and Characterization of Biosimilars
The biomanufacturing industry faces an unprecedented challenge with the emergence of biosimilars. The pathway to approval for biosimilars is a fluid process and several key aspects are still not determined. The University of Maryland and the National Institute of Standards and Technology (NIST) will deliver a one-day symposium on the current trends of characterization and production of biosimilars. On Friday, June 13, 2014 at 8:30 am join the thought-leaders, policy-makers, and creators of biosimilars as we present current trends, ideas, and predictions.
Bioanalytical Characterization of Biosimilars
Biosimilar Characterization: Perspectives from the Biopharma Industry
Dr. Thomas Fuerst, Director, Institute for Bioscience Biotechnology Research (IBBR)
Dr. Willie May, NIST Associate Director for Laboratory Programs
Dr. Darryll Pines, Dean, University of Maryland Clark School of Engineering
The Biomanufacturing Technology Summit registration fee for attendees is $99. Registration includes access to speaker presentations, panel sessions and content, plus breakfast, lunch, breaks, and the evening networking reception. Seating is limited so register today.